109 related articles for article (PubMed ID: 21933645)
21. Viral DNA detection and RAS mutations in actinic keratosis and nonmelanoma skin cancers.
Zaravinos A; Kanellou P; Spandidos DA
Br J Dermatol; 2010 Feb; 162(2):325-31. PubMed ID: 19849697
[TBL] [Abstract][Full Text] [Related]
22. A patient case highlighting the myriad of cutaneous adverse effects of prolonged use of hydroxyurea.
Neill B; Ryser T; Neill J; Aires D; Rajpara A
Dermatol Online J; 2017 Nov; 23(11):. PubMed ID: 29447639
[TBL] [Abstract][Full Text] [Related]
23. Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPN.
Antonioli E; Guglielmelli P; Pieri L; Finazzi M; Rumi E; Martinelli V; Vianelli N; Luigia Randi M; Bertozzi I; De Stefano V; Za T; Rossi E; Ruggeri M; Elli E; Cacciola R; Cacciola E; Pogliani E; Rodeghiero F; Baccarani M; Passamonti F; Finazzi G; Rambaldi A; Bosi A; Cazzola M; Barbui T; Vannucchi AM;
Am J Hematol; 2012 May; 87(5):552-4. PubMed ID: 22473827
[TBL] [Abstract][Full Text] [Related]
24. Multiple cutaneous precanceroses and carcinomas from combined iatrogenic/professional exposure to arsenic.
Torchia D; Massi D; Caproni M; Fabbri P
Int J Dermatol; 2008 Jun; 47(6):592-3. PubMed ID: 18477152
[No Abstract] [Full Text] [Related]
25. Cutaneous squamous-cell carcinoma in patients treated with PUVA.
Stern RS; Laird N; Melski J; Parrish JA; Fitzpatrick TB; Bleich HL
N Engl J Med; 1984 May; 310(18):1156-61. PubMed ID: 6709010
[TBL] [Abstract][Full Text] [Related]
26. Malignant melanoma and other second cutaneous malignancies in cutaneous T-cell lymphoma. The influence of additional therapy after total skin electron beam radiation.
Licata AG; Wilson LD; Braverman IM; Feldman AM; Kacinski BM
Arch Dermatol; 1995 Apr; 131(4):432-5. PubMed ID: 7726585
[TBL] [Abstract][Full Text] [Related]
27. The spectrum of cutaneous and internal malignancies in chronic arsenic toxicity.
Wong ST; Chan HL; Teo SK
Singapore Med J; 1998 Apr; 39(4):171-3. PubMed ID: 9676149
[TBL] [Abstract][Full Text] [Related]
28. Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin.
Karagas MR; Nelson HH; Sehr P; Waterboer T; Stukel TA; Andrew A; Green AC; Bavinck JN; Perry A; Spencer S; Rees JR; Mott LA; Pawlita M
J Natl Cancer Inst; 2006 Mar; 98(6):389-95. PubMed ID: 16537831
[TBL] [Abstract][Full Text] [Related]
29. bcl-2 vs p53 protein expression and apoptotic rate in human nonmelanoma skin cancers.
Wikonkal NM; Berg RJ; van Haselen CW; Horkay I; Remenyik E; Begany A; Hunyadi J; van Vloten WA; de Gruijl FR
Arch Dermatol; 1997 May; 133(5):599-602. PubMed ID: 9158413
[TBL] [Abstract][Full Text] [Related]
30. Hydroxyurea-induced squamous cell carcinoma.
Brown H; Lamrock E
Australas J Dermatol; 2021 Feb; 62(1):83-84. PubMed ID: 32895924
[No Abstract] [Full Text] [Related]
31. Specific types of human papillomavirus found in benign proliferations and carcinomas of the skin in immunosuppressed patients.
Shamanin V; Glover M; Rausch C; Proby C; Leigh IM; zur Hausen H; de Villiers EM
Cancer Res; 1994 Sep; 54(17):4610-3. PubMed ID: 8062252
[TBL] [Abstract][Full Text] [Related]
32. Detection of mucosal and cutaneous human papillomaviruses in oesophagitis, squamous cell carcinoma and adenocarcinoma of the oesophagus.
Tornesello ML; Monaco R; Nappi O; Buonaguro L; Buonaguro FM
J Clin Virol; 2009 May; 45(1):28-33. PubMed ID: 19307150
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemistry in ocular carcinomas.
Sramek B; Lisle A; Loy T
J Cutan Pathol; 2008 Jul; 35(7):641-6. PubMed ID: 18201230
[TBL] [Abstract][Full Text] [Related]
34. The different telomere lengths in basal and squamous cell carcinomas also differ between the nontransplant and renal transplant population.
Perrem K; Lynch A; Al Nooh F; Leader M; Elaine Kay
Hum Pathol; 2008 Jul; 39(7):1034-41. PubMed ID: 18482746
[TBL] [Abstract][Full Text] [Related]
35. Metastatic squamous cell carcinoma of the skin in chronic myeloid leukaemia: complication of hydroxyurea therapy.
Pamuk GE; Turgut B; Vural O; Demir M; Tek M; Altaner S
Clin Lab Haematol; 2003 Oct; 25(5):329-31. PubMed ID: 12974726
[TBL] [Abstract][Full Text] [Related]
36. Correlations among neural cell adhesion molecule, nerve growth factor, and its receptors, TrkA, TrkB, TrkC, and p75, in perineural invasion by basal cell and cutaneous squamous cell carcinomas.
Chen-Tsai CP; Colome-Grimmer M; Wagner RF
Dermatol Surg; 2004 Jul; 30(7):1009-16. PubMed ID: 15209791
[TBL] [Abstract][Full Text] [Related]
37. Iatrogenic immunosuppression and cutaneous malignancy.
DePry JL; Reed KB; Cook-Norris RH; Brewer JD
Clin Dermatol; 2011; 29(6):602-13. PubMed ID: 22014982
[TBL] [Abstract][Full Text] [Related]
38. Nonmelanoma skin cancer associated with Hydroxyurea treatment: Overview of the literature and our own experience.
Cantisani C; Kiss N; Naqeshbandi AF; Tosti G; Tofani S; Cartoni C; Carmosino I; Cantoresi F
Dermatol Ther; 2019 Sep; 32(5):e13043. PubMed ID: 31364787
[TBL] [Abstract][Full Text] [Related]
39. Detection of human papillomavirus DNA in primary lung carcinoma by nested polymerase chain reaction.
Thomas P; De Lamballerie X; Garbe L; Douagui H; Kleisbauer JP
Cell Mol Biol (Noisy-le-grand); 1995 Dec; 41(8):1093-7. PubMed ID: 8747090
[TBL] [Abstract][Full Text] [Related]
40. Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
Nand S; Stock W; Godwin J; Fisher SG
Am J Hematol; 1996 May; 52(1):42-6. PubMed ID: 8638610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
